(Q45255505)

English

Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type (English)

1 reference

Europe PubMed Central

11 December 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

F Licastro

1

1 reference

Europe PubMed Central

11 December 2017

M Chiappelli

2

1 reference

Europe PubMed Central

11 December 2017

M Ruscica

3

1 reference

Europe PubMed Central

11 December 2017

V Carnelli

4

1 reference

Europe PubMed Central

11 December 2017

M M Corsi

5

1 reference

Europe PubMed Central

11 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

11 December 2017

International Journal of Immunopathology and Pharmacology

1 reference

Europe PubMed Central

11 December 2017

18

1 reference

Europe PubMed Central

11 December 2017

1

1 reference

Europe PubMed Central

11 December 2017

165-172

1 reference

Europe PubMed Central

11 December 2017

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Glial cytokines in Alzheimer's disease: review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

The possible role of complement activation in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

The importance of inflammatory mechanisms in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Circulating cytokines in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Interleukin-6: a cytokine for gerontologists

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Neopterin, biochemistry and clinical use as a marker for cellular immune reactions

1 reference

https://api.crossref.org/works/10.1177%2F039463200501800117

21 January 2018

Identifiers

10.1177/039463200501800117

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45255505&oldid=2071797536"